2023 annual financial data
Oncolytics Biotech 2023 Operating margin
Oncolytics Biotech 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -25,471,883 CAD and net income was -20,919,644 CAD.
Operating cash flow was -21,444,293 CAD.
Get free Oncolytics Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -25,471,883 CAD
- Net income
- -20,919,644 CAD
- Operating cash flow
- -21,444,293 CAD